Related Experiment Videos
Graphene as multifunctional delivery platform in cancer therapy
Mojgan Nejabat1, Fahimeh Charbgoo2, Mohammad Ramezani2,3
1Department of Medicinal Chemistry, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Journal of Biomedical Materials Research. Part A
|April 4, 2017
Summary
Graphene-based nanomaterials offer enhanced drug and gene delivery for cancer therapy due to their high cargo capacity. This review explores advancements, benefits, and challenges of graphene in developing effective and biocompatible cancer treatment delivery systems.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Materials Science
Background:
- Graphene-based nanomaterials are increasingly utilized in biomedical applications, particularly for drug and gene delivery.
- Their high surface area enables significant cargo loading capacity, enhancing therapeutic potential.
- Graphene's ability to improve drug efficacy without increasing dosage is crucial for cancer treatment.
Purpose of the Study:
- To review recent advancements in graphene-based drug and gene delivery systems for cancer therapy.
- To analyze the advantages and disadvantages of various graphene materials for effective cargo delivery.
- To discuss strategies for mitigating the cytotoxic effects of graphene oxide and creating biocompatible platforms.
Main Methods:
- Literature review of recent studies on graphene-based nanomaterials in drug and gene delivery.
- Analysis of graphene material properties relevant to biomedical applications.
- Evaluation of methods for enhancing biocompatibility and reducing cytotoxicity of graphene-based systems.
Main Results:
- Graphene nanomaterials demonstrate high cargo loading capacity for efficient drug and gene delivery.
- Graphene can enhance chemotherapeutic efficacy in cancer treatment.
- Various graphene-based materials offer distinct advantages and disadvantages for delivery systems.
Conclusions:
- Graphene-based nanomaterials represent a promising platform for advanced cancer therapy delivery systems.
- Further research is needed to optimize biocompatibility and minimize potential cytotoxic impacts.
- Continued development of graphene delivery systems holds significant potential for improving cancer treatment outcomes.